Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Argus Health
Farmers Insurance
US Department of Justice
Teva
AstraZeneca
Citi

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019123

« Back to Dashboard

NDA 019123 describes KLOR-CON, which is a drug marketed by Upsher-smith Labs and is included in four NDAs. It is available from eighteen suppliers. Additional details are available on the KLOR-CON profile page.

The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and thirty-eight drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 019123
Tradename:KLOR-CON
Applicant:Upsher-smith Labs
Ingredient:potassium chloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019123
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KLOR-CON potassium chloride TABLET, EXTENDED RELEASE;ORAL 019123 NDA Upsher-Smith Laboratories, Inc. 0245-0040 0245-0040-00 1 BAG in 1 BOX (0245-0040-00) > 10000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BAG
KLOR-CON potassium chloride TABLET, EXTENDED RELEASE;ORAL 019123 NDA Upsher-Smith Laboratories, Inc. 0245-0040 0245-0040-01 10 BLISTER PACK in 1 CARTON (0245-0040-01) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0245-0040-89)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength8MEQ
Approval Date:Apr 17, 1986TE:AB2RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MEQ
Approval Date:Apr 17, 1986TE:AB2RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
Accenture
Queensland Health
Fish and Richardson
Express Scripts
UBS
Cerilliant
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.